−0.013AUD
−37.91 MAUD
6.17 B
About IMUGENE LIMITED
Sector
Industry
CEO
Leslie Chong
Website
Headquarters
Carlton
Founded
1986
ISIN
AU000000IMU9
FIGI
BBG000BZ3TD8
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IMU is 0.072 AUD — it has decreased by 7.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange IMUGENE LIMITED stocks are traded under the ticker IMU.
IMUGENE LIMITED is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
IMU stock is 12.68% volatile and has beta coefficient of 1.68. Check out the list of the most volatile stocks — is IMUGENE LIMITED there?
One year price forecast for IMUGENE LIMITED has a max estimate of 0.420 AUD and a min estimate of 0.420 AUD.
IMU earnings for the last quarter are 0.00 AUD whereas the estimation was 0.00 AUD which accounts for −73.33% surprise. Estimated earnings for the next quarter are 0.00 AUD. See more details about IMUGENE LIMITED earnings.
Yes, you can track IMUGENE LIMITED financials in yearly and quarterly reports right on TradingView.
IMU stock has fallen by 23.40% compared to the previous week, the month change is a 34.55% fall, over the last year IMUGENE LIMITED has showed a 50.34% decrease.
IMU net income for the last quarter is −68.71 M AUD, while the quarter before that showed −20.52 M AUD of net income which accounts for −234.83% change. Track more IMUGENE LIMITED financial stats to get the full picture.
Today IMUGENE LIMITED has the market capitalization of 607.54 M, it has decreased by 4.55% over the last week.
No, IMU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMUGENE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMUGENE LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMUGENE LIMITED stock shows the sell signal. See more of IMUGENE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IMUGENE LIMITED future price: according to them, IMU price has a max estimate of 0.42 AUD and a min estimate of 0.42 AUD. Read a more detailed IMUGENE LIMITED forecast: see what analysts think of IMUGENE LIMITED and suggest that you do with its stocks.